Brief: India's Zim Laboratories Dec Qtr Consol PAT Falls
06/02/2019 11:15
Feb 6 (Reuters) - Zim Laboratories Ltd ZIML.BO :
* DEC QUARTER CONSOL PAT 58.9 MILLION RUPEES VERSUS PROFIT
62.9
MILLION RUPEES YEAR AGO
* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 980.5 MILLION
RUPEES
VERSUS 750.9 MILLION RUPEES YEAR AGO
Source text - http://bit.ly/2UKlL7L
Further company coverage: ZIML.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia